Corporate Counsel: The AIA’s Impact on In-House Patent Processes

Originally Published in Corporate Counsel | February 7, 2014 | Lisa Shuchman

The America Invents Act, passed in 2011, created the biggest change to U.S. patent law in 60 years. So it’s probably not surprising that 59 percent of chief IP officers in the pharmaceuticals, biotechnology and medical device industries say the AIA has changed their in-house approach to the patent process, according to a new survey by Consero Group.

See full article here.